Proxyphylline
|
| Names
|
| IUPAC name
7-(2-Hydroxypropyl)-1,3-dimethylpurine-2,6-dione
|
| Identifiers
|
CAS Number
|
|
3D model (JSmol)
|
|
| ChEMBL
|
|
| ChemSpider
|
|
| DrugBank
|
|
| ECHA InfoCard
|
100.009.117
|
| EC Number
|
|
| KEGG
|
|
|
|
|
| UNII
|
|
|
|
|
InChI=1S/C10H14N4O3/c1-6(15)4-14-5-11-8-7(14)9(16)13(3)10(17)12(8)2/h5-6,15H,4H2,1-3H3 NKey: KYHQZNGJUGFTGR-UHFFFAOYSA-N N
|
CC(CN1C=NC2=C1C(=O)N(C(=O)N2C)C)O
|
| Properties
|
Chemical formula
|
C10H14N4O3
|
| Molar mass
|
238.24316
|
| Pharmacology
|
ATC code
|
R03DA03 (WHO)
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
|
Proxyphylline is a xanthine derivative that acts as a cardiac stimulant, vasodilator and bronchodilator.[1]
References
Drugs for obstructive airway diseases: asthma/COPD (R03) |
|---|
| Adrenergics, inhalants | | Short-acting β2 agonists | |
|---|
| Long-acting β2 agonists | |
|---|
| Ultra-long-acting β2 agonists |
- Abediterol
- Carmoterol
- Indacaterol
- Olodaterol
- Vilanterol
|
|---|
| Other | |
|---|
|
|---|
| Glucocorticoids | |
|---|
Anticholinergics/ muscarinic antagonist | |
|---|
| Mast cell stabilizers | |
|---|
| Xanthines | |
|---|
| Eicosanoid inhibition | | Leukotriene antagonists | |
|---|
| Arachidonate 5-lipoxygenase inhibitors | |
|---|
| Thromboxane receptor antagonists | |
|---|
| Non-xanthine PDE4 inhibitors | |
|---|
|
|---|
| Others/unknown | |
|---|
| Combination products |
- Aclidinium bromide/formoterol
- Beclometasone/formoterol
- Beclometasone/formoterol/glycopyrronium bromide
- Budesonide/formoterol
- Budesonide/glycopyrronium bromide/formoterol
- Fluticasone furoate/umeclidinium bromide/vilanterol
- Fluticasone furoate/vilanterol
- Fluticasone propionate/salmeterol
- Glycopyrronium bromide/formoterol
- Indacaterol/glycopyrronium bromide
- Indacaterol/glycopyrronium bromide/mometasone
- Indacaterol/mometasone
- Ipratropium bromide/salbutamol
- Mometasone/formoterol
- Salbutamol (albuterol)/budesonide
- Theophylline/ephedrine
- Theophylline/ephedrine/hydroxyzine
- Theophylline/ephedrine/phenobarbital
- Umeclidinium bromide/vilanterol
|
|---|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
|
Purine receptor modulators |
|---|
Receptor (ligands) | |
|---|
Transporter (blockers) | | CNTsTooltip Concentrative nucleoside transporters | |
|---|
| ENTsTooltip Equilibrative nucleoside transporters | |
|---|
| PMATTooltip Plasma membrane monoamine transporter | |
|---|
|
|---|
Enzyme (inhibitors) | | XOTooltip Xanthine oxidase | |
|---|
| Others | |
|---|
|
|---|
| Others | |
|---|
See also: Receptor/signaling modulators |
Phosphodiesterase inhibitors |
|---|
| PDE1 | |
|---|
| PDE2 |
- BAY 60-7550
- Carbazeran
- EHNA
- Oxindole
- PDP
|
|---|
| PDE3 | |
|---|
| PDE4 |
- Apremilast
- Arofylline
- Atizoram
- Benafentrine
- Catramilast
- CC-1088
- CDP-840
- CGH-2466
- Cilomilast
- Cipamfylline
- Crisaborole
- Denbutylline
- Difamilast
- Drotaverine
- Ensifentrine
- Etazolate
- Filaminast
- Glaucine
- HT-0712
- ICI-63197
- Indimilast
- Irsogladine
- Lavamilast
- Lirimilast
- Lotamilast
- Luteolin
- Mesembrenone
- Mesembrine
- Mesopram
- Oglemilast
- Piclamilast
- Pumafentrine
- Revamilast
- Ro 20-1724
- Roflumilast
- Rolipram
- Ronomilast
- RPL-554
- RS-25344
- Tetomilast
- Tofimilast
- YM-976
- Zardaverine
|
|---|
| PDE5 |
- Acetildenafil
- Aildenafil
- Avanafil
- Beminafil
- Benzamidenafil
- Dasantafil
- Icariin
- Gisadenafil
- Homosildenafil
- Lodenafil
- Mirodenafil
- MY-5445
- Nitrosoprodenafil
- Norcarbodenafil
- SCH-51866
- Sildenafil
- Sulfoaildenafil
- T-0156
- Tadalafil
- Udenafil
- Vardenafil
|
|---|
| PDE7 | |
|---|
| PDE9 | |
|---|
| PDE10 |
- Balipodect
- Mardepodect
- MK-8189
- Papaverine
- TC-E 5005
- Tofisopam
|
|---|
| PDE11 | BC11-38 |
|---|
| Non-selective | |
|---|
| Unsorted | |
|---|
See also: Receptor/signaling modulators |